Surface expression of inhibitory (CTLA-4) and stimulatory (OX40) receptors by CD4+ regulatory T cell subsets circulating in human malaria

Microbes and Infection

Volumn 18, Issue 10, 2016, Pages 639-648

  Gonçalves Lopes, Raquel M ^a   Lima, Nathália F ^a   Carvalho, Karina I ^a,b   Scopel, Kézia K G ^c   Kallás, Esper G ^a   Ferreira, Marcelo U ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

CTLA 4; Human malaria; Immunoregulation; OX 40; Treg cells

Indexed keywords

CD134 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR 2; TNFRSF4 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; PARASITE CLEARANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PHENOTYPE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; CHEMISTRY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CTLA-4 ANTIGEN; FEMALE; HOMEOSTASIS; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED; RECEPTORS, OX40; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84989159446     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2016.06.003     Document Type: Article

References (50)

1. [1] Langhorne, J., Ndungu, F.M., Sponaas, A.M., Marsh, K., Immunity to malaria: more questions than answers. Nat Immunol 9 (2008), 725–732.
2. [2] Troye-Blomberg, M., Romero, P., Patarroyo, M.E., Björkman, A., Perlmann, P., Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol 58 (1984), 380–387.
3. [3] Ho, M., Webster, H.K., Looareesuwan, S., Supanaranond, W., Phillips, R.E., Chanthavanich, P., et al. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis 153 (1986), 763–771.
4. [4] Riley, E.M., Andersson, G., Otoo, L.N., Jepsen, S., Greenwood, B.M., Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin Exp Immunol 73 (1988), 17–22.
5. [5] Goonewardene, R., Carter, R., Gamage, C.P., Del Giudice, G., David, P.H., Howie, S., et al. Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria. Eur J Immunol 20 (1990), 1387–1391.
6. [6] Braga, E.M., Carvalho, L.H., Fontes, C.J., Krettli, A.U., Low cellular response in vitro among subjects with long-term exposure to malaria transmission in Brazilian endemic areas. Am J Trop Med Hyg 66 (2002), 299–303.
7. [7] Hansen, D.S., Schofield, L., Natural regulatory T cells in malaria: host or parasite allies?. PLoS Pathog, 6, 2010, e1000771.
8. [8] Scholzen, A., Minigo, G., Plebanski, M., Heroes or villains? T regulatory cells in malaria infection. Trends Parasitol 26 (2010), 16–25.
9. [9] Finney, O.C., Riley, E.M., Walther, M., Regulatory T cells in malaria–friend or foe?. Trends Immunol 31 (2010), 63–70.
10. + regulatory T cell function. Science 322 (2008), 271–275.
11. [11] Walker, L.S., Sansom, D.M., Confusing signals: recent progress in CTLA-4 biology. Trends Immunol 36 (2015), 63–70.
12. [12] Ruby, C.E., Yates, M.A., Hirschhorn-Cymerman, D., Chlebeck, P., Wolchok, J.D., Houghton, A.N., et al. Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right. J Immunol 183 (2009), 4853–4857.
13. [13] Croft, M., Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 28 (2010), 57–78.
14. [14] Nocentini, G., Riccardi, C., GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 35 (2005), 1016–1022.
15. + regulatory T cells. Immunology 133 (2011), 426–433.
16. [16] González-Amaro, R., Cortés, J.R., Sánchez-Madrid, F., Martín, P., Is CD69 an effective brake to control inflammatory diseases?. Trends Mol Med 19 (2013), 625–632.
17. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110 (2007), 1225–1232.
18. [18] Baecher-Allan, C., Wolf, E., Hafler, D.A., MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 176 (2006), 4622–4631.
19. [19] Karimi, S., Chattopadhyay, S., Chakraborty, N.G., Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy. Immunology 144 (2015), 186–196.
20. + cells induced in utero as a consequence of placental Plasmodium falciparum infection. J Infect Dis 193 (2006), 146–154.
21. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23 (2005), 287–296.
22. + CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog, 5, 2009, e1000364.
23. [23] Finney, O.C., Nwakanma, D., Conway, D.J., Walther, M., Riley, E.M., Homeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission. Eur J Immunol 39 (2009), 1288–1300.
24. [24] Minigo, G., Woodberry, T., Piera, K.A., Salwati, E., Tjitra, E., Kenangalem, E., et al. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog, 5, 2009, e1000402.
25. + regulatory CD4 T cells in peripheral blood of children heavily exposed to malaria. PLoS Pathog, 11, 2015, e1005041.
26. + regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses?. Infect Immun 78 (2010), 4763–4772.
27. [27] Torres, K.J., Villasis, E., Bendezú, J., Chauca, J., Vinetz, J.M., Gamboa, D., Relationship of regulatory T cells to Plasmodium falciparum malaria symptomatology in a hypoendemic region. Malar J, 13, 2014, 108.
28. [28] Jangpatarapongsa, K., Chootong, P., Sattabongkot, J., Chotivanich, K., Sirichaisinthop, J., Tungpradabkul, S., et al. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 38 (2008), 2697–2705.
29. + regulatory T cells during infection are directly associated with level of circulating parasites. PLoS One, 5, 2010, e9623.
30. [30] Jangpatarapongsa, K., Xia, H., Fang, Q., Hu, K., Yuan, Y., Peng, M., et al. Immunity to malaria in Plasmodium vivax infection: a study in central China. PLoS One, 7, 2012, e45971.
31. [31] Barbosa, S., Gozze, A.B., Lima, N.F., Batista, C.L., Bastos Mda, S., Nicolete, V.C., et al. Epidemiology of disappearing Plasmodium vivax malaria: a case study in rural Amazonia. PLoS Negl Trop Dis, 8, 2014, e3109.
32. + T regulatory cells correlates with progressive disease. J Virol 85 (2011), 1287–1297.
33. + T cells in HIV infection. Clin Exp Immunol 115 (1999), 451–457.
34. [34] Schlotmann, T., Waase, I., Jülch, C., Klauenberg, U., Müller-Myhsok, B., Dietrich, M., et al. CD4 αβ T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria. J Infect Dis 182 (2000), 367–370.
35. [35] Intlekofer, A.M., Thompson, C.B., At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. J Leukoc Biol 94 (2013), 25–39.
36. [36] Zander, R.A., Obeng-Adjei, N., Guthmiller, J.J., Kulu, D.I., Li, J., Ongoiba, A., et al. PD-1 Co-inhibitory and OX40 co-stimulatory crosstalk regulates helper T cell differentiation and anti-Plasmodium humoral immunity. Cell Host Microbe 17 (2015), 628–641.
37. [37] Corse, E., Allison, J.P., Cutting edge: CTLA-4 on effector T cells inhibits in trans. J Immunol 189 (2012), 1123–1127.
38. [38] Wang, C.J., Kenefeck, R., Wardzinski, L., Attridge, K., Manzotti, C., Schmidt, E.M., et al. Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells. J Immunol 189 (2012), 1118–1122.
39. - T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-β 1. J Immunol 182 (2009), 111–120.
40. [40] Gandhi, R., Farez, M.F., Wang, Y., Kozoriz, D., Quintana, F.J., Weiner, H.L., Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. J Immunol 184 (2010), 4620–4624.
41. [41] Oakley, M.S., Majam, V., Mahajan, B., Gerald, N., Anantharaman, V., Ward, J.M., et al. Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice. PLoS One, 4, 2009, e6793.
42. [42] Croft, M., The TNF family in T cell differentiation and function–unanswered questions and future directions. Semin Immunol 26 (2014), 183–190.
43. - T-cell subsets in cancer patients. Eur J Immunol 42 (2012), 1876–1885.
44. + immunoregulatory T cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl Trop Dis, 7, 2013, e2028.
45. + T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 105 (2005), 2845–2851.
46. [46] Takeda, I., Ine, S., Killeen, N., Ndhlovu, L.C., Murata, K., Satomi, S., et al. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 172 (2004), 3580–3589.
47. [47] Redmond, W.L., Linch, S.N., Kasiewicz, M.J., Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity. Cancer Immunol Res 2 (2014), 142–153.
48. [48] Costa, P.A., Leoratti, F.M., Figueiredo, M.M., Tada, M.S., Pereira, D.B., Junqueira, C., et al. Induction of inhibitory receptors on T cells during Plasmodium vivax malaria impairs cytokine production. J Infect Dis 212 (2015), 1999–2010.
49. [49] Butler, N.S., Moebius, J., Pewe, L.L., Traore, B., Doumbo, O.K., Tygrett, L.T., et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 13 (2011), 188–195.
50. [50] Hafalla, J.C., Claser, C., Couper, K.N., Grau, G.E., Renia, L., de Souza, J.B., et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS Pathog, 8, 2012, e1002504.